UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future

BMC medicine, 2011-09, Vol.9 (1), p.107-107, Article 107

2011

Volltextzugriff (PDF)

Health-care workers: source, vector, or victim of MRSA?

The Lancet infectious diseases, 2008-05, Vol.8 (5), p.289-301

2008

Volltextzugriff (PDF)

Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?

American journal of respiratory and critical care medicine, 2023-08, Vol.208 (3), p.230-231

2023

Volltextzugriff (PDF)

Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection

PloS one, 2021-07, Vol.16 (7), p.e0253161-e0253161

2021

Volltextzugriff (PDF)

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Intensive Care Medicine, 2015-10, Vol.41 (10), p.1739-1751

2015

Volltextzugriff (PDF)

Levofloxacin prophylaxis in patients with myeloma

The lancet oncology, 2020-02, Vol.21 (2), p.e68-e68

2020

Volltextzugriff (PDF)

Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-06, Vol.323 (21), p.2160

2020

Volltextzugriff (PDF)

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2

Virology journal, 2020-09, Vol.17 (1), p.136-136, Article 136

2020

Volltextzugriff (PDF)

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)

Frontiers in immunology, 2022-01, Vol.12, p.628741-628741

2022

Volltextzugriff (PDF)

Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial

The lancet respiratory medicine, 2022-09, Vol.10 (9), p.877-887

2022

Volltextzugriff (PDF)

Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e2869-e2874

2021

Volltextzugriff (PDF)

The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens

PloS one, 2016-03, Vol.11 (3), p.e0151428-e0151428

2016

Volltextzugriff (PDF)

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm

BMC infectious diseases, 2011-05, Vol.11 (1), p.112-112, Article 112

2011

Volltextzugriff (PDF)

Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial

PloS one, 2017-06, Vol.12 (6), p.e0178669-e0178669

2017

Volltextzugriff (PDF)

Measles in Returning Adult Travelers

The American journal of tropical medicine and hygiene, 2018-07, Vol.99 (1), p.5-6

2018

Volltextzugriff (PDF)

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

Oncoimmunology, 2021-01, Vol.10 (1), p.1988403-1988403

2021

Volltextzugriff (PDF)

Guideline of the Swiss Society of Gynaecology and Obstetrics (SSGO) on acute and recurrent urinary tract infections in women, including pregnancy

Swiss medical weekly, 2020-05, Vol.150 (1920), p.w20236

2020

Volltextzugriff (PDF)

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (7), p.678-691

2023

Volltextzugriff (PDF)

Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID‐19

Allergy (Copenhagen), 2022-05, Vol.77 (5), p.1623-1625

2022

Volltextzugriff (PDF)

Biofilm formation on ureteral stents - Incidence, clinical impact, and prevention

Swiss medical weekly, 2017-02, Vol.147, p.w14408

2017

Volltextzugriff (PDF)

Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland

Infection, 2023-04, Vol.51 (2), p.439-446

2023

Volltextzugriff (PDF)

The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review

Expert review of respiratory medicine, 2023-10, Vol.17 (10), p.919-927, Article 919

2023

Volltextzugriff (PDF)

A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2

Gut microbes, 2022, Vol.14 (1), p.2073131-2073131

2022

Volltextzugriff (PDF)

Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland

Scientific reports, 2022-11, Vol.12 (1), p.19826-19826, Article 19826

2022

Volltextzugriff (PDF)

How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study

Clinical microbiology and infection, 2022-02, Vol.28 (2), p.297.e1-297.e6

2022

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(139)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(130)
Life Sciences & Biomedicine
(123)
Humans
(87)
Infectious Diseases
(49)
Male
(35)
Female
(34)
General & Internal Medicine
(30)
Middle Aged
(29)
Pneumonia
(29)
Adult
(27)
Aged
(27)
Covid-19
(27)
Antibiotics
(26)
Anti-Bacterial Agents - Therapeutic Use
(24)
Medicine, General & Internal
(24)
Patients
(22)
Microbiology
(21)
Switzerland
(20)
Infections
(19)
Immunology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Forum Médical Suisse
(7)
Swiss Medical Forum
(7)
Swiss Medical Weekly
(7)
Clinical Infectious Diseases
(6)
Infection
(6)
Bmc Infectious Diseases
(5)
Alimentary Pharmacology & Therapeutics
(4)
Plos One
(4)
Pneumonia
(4)
Praxis
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future

Health-care workers: source, vector, or victim of MRSA?

Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?

Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Levofloxacin prophylaxis in patients with myeloma

Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)

Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial

Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies

The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm

Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial

Measles in Returning Adult Travelers

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

Guideline of the Swiss Society of Gynaecology and Obstetrics (SSGO) on acute and recurrent urinary tract infections in women, including pregnancy

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease

Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID‐19

Biofilm formation on ureteral stents - Incidence, clinical impact, and prevention

Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland

The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review

A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2

Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland

How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study

Suchergebnisse filtern